Vasoconstrictor activity of coronary sinus plasma from patients with coronary artery disease.

[1]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[2]  E. Nabel,et al.  Active transient myocardial ischemia during daily life in asymptomatic patients with positive exercise tests and coronary artery disease. , 1986, The American journal of cardiology.

[3]  C. Benedict,et al.  Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. , 1986, Circulation.

[4]  V. Miller,et al.  Modulation of vascular smooth muscle contraction by the endothelium. , 1986, Annual review of physiology.

[5]  K. Tanaka,et al.  Coronary artery spasm induced in miniature swine: angiographic evidence and relation to coronary atherosclerosis. , 1985, American heart journal.

[6]  P. Vanhoutte,et al.  Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. , 1985, The Journal of physiology.

[7]  P. Lorenz,et al.  Intracoronary platelet activation in ischemic heart disease: effects of ticlopidine. , 1985, American heart journal.

[8]  J. T. Shepherd,et al.  Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets. , 1985, The American journal of physiology.

[9]  G. Rubanyi,et al.  Inhibitors of Prostaglandin Synthesis Augment β‐Adrenergic Responsiveness in Canine Coronary Arteries , 1985, Circulation research.

[10]  P. Vanhoutte,et al.  Spasm of the coronary arteries: causes and consequences (the scientist's viewpoint). , 1985, Mayo Clinic proceedings.

[11]  A. Bove,et al.  Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs. , 1984, Circulation.

[12]  A. Koller,et al.  Possible role of nickel ions in the pathogenesis of ischemic coronary vasoconstriction in the dog heart. , 1984, Journal of molecular and cellular cardiology.

[13]  J. T. Shepherd,et al.  5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. , 1983, The American journal of physiology.

[14]  R. Furchgott.  Role of endothelium in responses of vascular smooth muscle. , 1983, Circulation research.

[15]  M. LeWinter,et al.  Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.

[16]  J. T. Shepherd,et al.  Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. , 1983, Science.

[17]  G. Santoro,et al.  Silent myocardial ischemia during ambulatory electrocardiographic monitoring in patients with effort angina. , 1983, Journal of the American College of Cardiology.

[18]  B. Kirchhof,et al.  Determination of prothrombin by a micro-coagulation method. , 1983, Haemostasis.

[19]  R. Roncucci,et al.  Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications. , 1983, Haemostasis.

[20]  J. Alpert,et al.  Coronary spasm, coronary thrombosis, and myocardial infarction: a hypothesis concerning the pathophysiology of acute myocardial infarction. , 1982, American heart journal.

[21]  K. Fox,et al.  EFFECTS OF PLATELET INHIBITION ON MYOCARDIAL ISCHAEMIA , 1982, The Lancet.

[22]  P. Cannon,et al.  Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease. , 1982, Blood.

[23]  E. Frenkel,et al.  Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: direct evidence for enhanced platelet reactivity in vivo. , 1981, The American journal of cardiology.

[24]  J. Lindenfeld,et al.  Increased Plasma Concentrations of Platelet Factor 4 in Coronary Artery Disease: A Measure of In Vivo Platelet Activation and Secretion , 1981, Circulation.

[25]  E. Braunwald.  Coronary artery spasm as a cause of myocardial ischemia. , 1981, The Journal of laboratory and clinical medicine.

[26]  I. Mühlhauser,et al.  Plasma Concentrations of Platelet-Specific Proteins in Coronary Artery Disease , 1981 .

[27]  E. Genton.  A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease. , 1980, Circulation.

[28]  G. Mcnicol.  ANTIPLATELET DRUGS IN THE SECONDARY PREVENTION OF MYOCARDIAL INFARCTION One View of the Present Position , 1980, The Lancet.

[29]  R. Macalpin,et al.  Relation of coronary arterial spasm to sites of organic stenosis. , 1980, The American journal of cardiology.

[30]  S. Chierchia,et al.  Significance of spasm in the pathogenesis of ischemic heart disease. , 1979, The American journal of cardiology.

[31]  J. Mehta,et al.  Platelet aggregation across the myocardial vascular bed in man: I. Normal versus diseased coronary arteries. , 1979, Thrombosis research.

[32]  J. Gormsen,et al.  ADP-induced platelet aggregation in vitro in patients with ischemic heart disease and peripheral thromboatherosclerosis. , 2009, Acta medica Scandinavica.

[33]  J. Ritchie,et al.  Platelet and fibrinogen survival in coronary atherosclerosis , 1977 .

[34]  P. Steele,et al.  Platelet Function Studies in Coronary Artery Disease , 1973, Circulation.

[35]  H. H. Keller,et al.  Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs. , 1973, European journal of pharmacology.

[36]  Hugh Ae,et al.  THE WORK OF THE FAMILY DOCTOR. , 1963 .

[37]  L. Horlick.  Platelet adhesiveness in normal persons and subjects with atherosclerosis. Effect of high fat meals and anti-coagulants on the adhesive index. , 1961, The American journal of cardiology.